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Abstract There has been recent concern regarding the
safety of cervical epidural steroid injections. The decision
to proceed with treatment requires balancing the risk and
benefits. This article is an in depth review of the efficacy,
complications, and technique of both interlaminar and
transforaminal cervical epidural steroid injections in the
management of cervical radiculitis.
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Introduction
Cervical radiculitis affects approximately 83 per 100,000
population per year [1]. The most common causes of cer-
vical radiculitis in this study were herniated disk in 21.9%
and spondylosis in 68.4%. The majority of those affected
did not undergo surgery. Outcomes are favorable in both
surgical and non-surgically treated groups without repro-
ducible significant outcome differences of one treatment
over the other [1–3]. The favorable outcome from cervical
radiculitis from herniated disk may be due in part to the
natural regression of disk herniation over time [4, 5].
However, well-designed randomized trials of surgical
outcome and non-surgical outcome for specific diagnostic
entities have not been performed. Current treatment strat-
egies typically involve a gradual progression in the
aggressiveness of intervention, progressing from less to
more invasive interventions only in refractory cases.
Initial treatment usually consists of activity modifica-
tion, NSAID’s, and physical therapy. Narcotic analgesics
and analgesic adjuvants may be needed when pain is not
adequately controlled. A cervical orthosis may provide
comfort for some patients in the acute phase. If there is no
improvement in 3–4 weeks of conservative treatment,
cervical epidural steroid injections may be performed.
The rationale for corticosteroid instillation is the anti-
inflammatory affect. Cervical herniated disk specimens
have demonstrated increased levels of matrix metallopro-
teinase activity, nitric oxide, prostaglandin E2, and
interleukin-6 [6, 7]. Phospholipase A2 also plays a role in
the inflammation of the nerve root and can be neurotoxic
[8–10]. Epidural steroids have been shown to inhibit
phospholipase A2 activity, thus reducing symptoms [10].
Corticosteroid mitigates nerve conduction slowing due to
inflammation [11]. Corticosteroids also affect cell-medi-
ated activity and cytokines, which may be involved in the
pathogenesis of radicular pain [12].
Corticosteroids have actions other than anti-inflamma-
tory. Corticosteroids stabilize nerve membranes inhibiting
ectopic impulses [13], inhibits ion conductance [14],
hyperpolarizes spinal neurons [15], and inhibits C fiber
transmission [16]. These latter properties of corticosteroids
can explain relief of symptoms in non-inflammatory states.
Local anesthetic mixed with the corticosteroid may have
additional benefits beyond the direct anesthetic affects.
Lidocaine has been shown to have anti-inflammatory effect
on nucleus pulposus induced nerve injury [17]. Lidocaine
has been demonstrated to increase intra-radicular blood
flow in an animal compressed nerve root model [18]. This
may improve intra-neural metabolism and reduce inflam-
matory mediators.
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The efficacy, complications, side-effects, and technique
for interlaminar and transforaminal cervical epidural ste-
roid injections are reviewed. Because of the paucity of
studies, blinded interlaminar cervical epidural steroid
injections are included in the review. However, the author
does not condone the use of blinded interlaminar injections,
which should become evident to the reader upon comple-
tion of this review.
Efficacy
Cervical epidural steroid injections (CESI) have been uti-
lized for decades in the treatment of radicular pain. Over
time the techniques in delivering corticosteroid into the
epidural space has changed. Initial injections were per-
formed blind—without fluoroscopy. Table 1 summarizes
the following studies.
Blind interlaminar CESI
Rowlingson and Kirschenbaum [19] retrospectively present
their results on 25 subjects with cervical radiculopathy who
underwent 45 blind interlaminar CESI at C6-7 or C7-T1.
Advanced imaging with CT and/or Myelography was
performed in only 12 of the subjects. A compressive lesion
was found in nine. Whether the compressive lesion corre-
lated with the subject’s symptoms was not stated. Average
follow-up was 8.9 months. Excellent response defined as
complete resolution of symptoms occurred in 24%.
Symptom improvement of greater than 75% occurred in
40%. Three subjects had no improvement.
Mangar and Thomas [20] briefly report their results for
40 subjects who underwent 117 blind interlaminar CESI for
cervical radiculitis. Greater than 70% pain relief and more
than 50% relief were reported in 38% and 7%, respectively.
No relief occurred in 32%. However, 75% of subjects with
Table 1 Summary of CESI outcomes. Under diagnosis, mixed indicates inclusion of subjects with neck pain only and neck and arm pain. Under
type of CESI, blind refers to interlaminar injections performed without fluoroscopic guidance. TF indicates fluoroscopically guided transfora-
minal injection. IL indicates fluoroscopically guided interlaminar injection. See text for further descriptions of studies
Investigators Study design N Diagnosis CESI type F/U Outcome
Rowlings and
Kirschenbaum
Retrospective 25 Non-specific Blind 8.9 months 24% excellent
40% [75% relief
Mangar and Thomas Observational 40 HNP Spondylosis Blind Not stated 38% [70% relief
7% [50% relief
32% no relief
Ferrante Retrospective 100 Mixed Blind 13.5 months 62% with radiculitis with [50% relief
Stav Randomized 60 Mixed Blind 1 year [50% decrease VAS
ESI: 68%
T.P. 11.8%
Castagnera Randomized 24 Chemical radiculitis Blind 3 months VAS 87% decrease
Steroid:lidocaine = Steroid:morphine
Grenier Prospective 29 Chemical radiculitis Blind 2 years 83% Success
Bush and Hillier Prospective 68 HNP spondylosis Plexus TF
IL
39 months 76% Relief of arm pain
84% Full work capacity
Bush Prospective 13 HNP Blind TF IL 12 months 12 Complete relief & resolution of
HNP
Vallee Prospective 32 HNP spondylosis TF 6 months 56% [50% relief
Cyteval Observational 30 HNP spondylosis TF-CT
guided
6 months 18/30 VAS decreased from 6.3 to 0.7
Slipman Retrospective 22 Chemical radiculitis after
MVA
TF 33.3 months 14% Good to excellent
VAS: 73.3 to 50.7
Slipman Retrospective 15 Spondylosis with trauma TF 20.7 months 20% Good to excellent
Slipman Retrospective 20 Spondylosis no trauma TF 21.2 months 60% Good to excellent
VAS: 6.9 to 2.0
Lin Retrospective 70 HNP TF 13 months 65.3% Good to excellent
Anderberg Randomized 40 Spondylosis TF 3 weeks Carbocaine with steroid vs. saline
No difference
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herniated disk had improvement. Time from treatment to
analysis was not reported in this retrospective review.
Ferrante et al. [21] retrospectively analyzed records of
100 subjects who underwent 235 blind midline interlami-
nar CESI for radicular or axial pain. Of those with
radiculopathy, 62% had greater than or equal to 50% pain
relief. Of those with cervical radiculitis with structural
abnormality on imaging, only 35% had 50% or better pain
relief.
Stav et al. [22] performed a prospective, randomized
trial of blind interlaminar CESI (group A), posterior muscle
trigger point with steroid:anesthetic mixture (group B), and
intra-muscular lidocaine injection (group C). Group C
consisted of 10 subjects who were later divided equally
into groups A and B. Groups A and B initially consisted of
25 subjects each, but 8 in group B were later excluded
secondary to litigation. Inclusion was neck and neck with
radicular pain from cervical disk disease or spondylosis
that failed physical therapy and medications. Groups A and
B received 3 injections performed every 2 weeks. Outcome
was considered very good for 75% decrease and good for
50–74% decrease in VAS. At 1 year, very good or good
relief was 68% and 11.8% for groups A and B, respec-
tively. Group C had poor results in all subjects at 3–4 week
follow-up. The results suggest benefit from CESI.
The observational studies suggest a success rate of 40–
62% for blind, interlaminar CESI for cervical radiculopa-
thy. The one prospective, randomized trial demonstrated
superiority of blind, interlaminar CESI over trigger point
injection for radicular pain. However, the actual diagnosis
of subjects in these studies is elusive. Treatment outcomes
will be dependent upon a specific diagnosis. Mangar and
Thomas [20] support this premise noting 75% of subjects
with a herniated disk had improvement, while overall
success rate in their study was only 45%.
For blind, interlaminar CESI only two studies were
performed for a specific diagnostic group. Chemical
radiculitis is defined as radicular pain in the absence of
nerve root compression on imaging studies [23]. Castag-
nera et al. [24] randomized 24 subjects suffering from
cervical chemical radiculitis treated with blind interlaminar
CESI with steroid/lidocaine combination versus interlami-
nar CESI with steroid/morphine sulfate combination. At
3 months, there was no difference between groups with
mean VAS decrease of 87% for both groups. The authors
concluded there is no advantage to the addition of mor-
phine to CESI. Grenier et al. [25] prospectively report on
29 subjects who underwent one blind interlaminar CESI at
C7-T1 for chemical radiculitis with 83% success rate at
3 month follow-up that remained for 2 years.
Blind, interlaminar CESI may be misplaced 53% of the
time utilizing the loss of resistance technique [26]. Hence,
studies performed with blind, interlaminar CESI have been
criticized for probably underestimating efficacy. Fluoros-
copy with conformation utilizing non-ionic contrast agent




Bush and Hillier [27] prospectively evaluated with an
independent review of 68 consecutive subjects suffering
from cervical radiculopathy. Cervical spondylosis was
present in 30% and herniated disk in 70% of subjects.
Subjects received a cervical brachial plexus block. If no
relief the subjects progressed to fluoroscopically guided
transforaminal CESI and lastly, fluoroscopically guided
interlaminar CESI. Twenty-nine percent had relief with
brachial plexus injection, 62% with transforaminal CESI,
and 16% interlaminar CESI. At mean follow-up of
39 months (range 4–112), 76% had complete relief of arm
pain and 24% had average pain score of 2. Prior to treat-
ment 75% had weakness. At follow-up 73% no longer
experienced weakness. Eighty-four percent did not feel
their symptoms interfered with their capacity to work.
Bush et al. [5] prospectively reported on 13 subjects
with cervical radiculopathy from HNP that received either
a blind injection, fluoroscopically guided transforaminal
CESI or interlaminar CESI. An average follow-up of
12 months (range, 4–31 months) underwent telephone
interview and repeat MRI. Twelve of thirteen had resolu-
tion of the herniated nucleus pulposus. The one subject
with persistent herniated nucleus pulposus on MRI had
residual neck pain.
While the above studies suggest CESI’s are beneficial in
the management of cervical radicular pain from a herniated
disk, the lack of a control group does not exclude the
improvement being secondary to the favorable natural
history of cervical disk herniation. Saal et al. [28] experi-
enced an 83% success rate for non-operative management
of radiculopathy from a cervical disk herniation in 26
subjects. Treatment consisted of relative rest, modalities,
hard cervical collar, medications, and physical therapy.
Nine subjects with persistent symptoms underwent either
fluoroscopically guided interlaminar or transforaminal
CESI. Follow-up was over 1 year in all subjects.
Fluoroscopically guided transforaminal CESI
Fluoroscopy allowed the development of transforaminal
CESI’s. Transforaminal epidural injections have the
advantage of being able to place medication directly
around the dorsal root ganglion pathologically involved in
causing a patient’s radicular pain. Medication in the epi-
dural space will tend to flow in the direction of least
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resistance. With interlaminar paramedian cervical epidural
injections, the medication tends to spread unilateral in 51%
and ventral in only 28% [26]. The authors utilized a 2-ml
volume stating larger volumes could result in dilution of
corticosteroid at the site of pathology. In a separate study
with a midline approach, ventral flow occurred in 44.6% of
epidural injections with volumes ranging from 2 to 4 ml
[29]. Foraminal and entrance zone disk herniations, cervi-
cal spondylotic foraminal stenosis, and epidural fibrosis
can potentially block the flow of medication from an
interlaminar epidural injection to the involved dorsal root
ganglion. Hence, interventionalists seeking to improve
efficacy began to perform transforaminal epidural steroid
injections to put medication at the site of pathology.
Anderberg et al. [30] performed a prospective, ran-
domized study of radicular pain from cervical spondylosis
with positive MRI finding and 50% or greater relief with
diagnostic selective nerve root injection. Subjects were
randomized to receive either 0.5 ml Carbocain and 1 ml
steroid (40 mg methylprednisolone) or 0.5 ml Carbocain
and 1 ml saline transforaminal cervical epidural injection
with fluoroscopic guidance. Follow-up was performed at
3 weeks. Twenty subjects were in each group with sub-
jective improvement in pain occurred in 8 in the steroid
group and 7 in the saline group. There was no statistical
significance between groups.
Vallee et al. [31] prospectively evaluated transforaminal
CESI performed on 32 consecutive subjects with radicular
pain from foraminal stenosis either from spondylosis or
disk herniation. At 6 months follow-up greater than 50%
relief occurred in 56% who also resumed full activities.
Cyteval et al. [32] report on 30 subjects with cervical
radiculopathy from either spondylotic foraminal stenosis
(16 subjects) or foraminal disk protrusion (14 subjects). All
subjects had persistent symptoms despite 1 month of
physical therapy and medication management. Subjects
underwent one CT-guided transforaminal CESI. Eighteen
subjects had good to excellent pain relief at 2 weeks with
average VAS decreasing from 6.3 to 1.2. At 6 months these
18 subjects had mean VAS of 0.7. For the 12 subjects with
fair or poor results at 2 weeks, 3 had a second CT-guided
transforaminal CESI. At 2 weeks from the second injection
2 subjects had greater than 75% relief (excellent) and 1
with less than 25% relief (poor).
Slipman et al. [33] retrospectively evaluated 22 subjects
with radicular pain without a compressive lesion on
imaging studies following a motor vehicle accident. All
subjects had at least 80% pain reduction from a diagnostic
cervical selective nerve root injection. Additionally, all
subjects had greater arm than neck pain. Mean follow-up
was 33.3 months (range 4–65 months). An average of 2.1
injections was performed. A steroid effect occurred in
59%. Only 14% had a good to excellent outcome, based
upon VAS, Oswestry, work status, and medication usage.
Average Oswestry score at presentation and follow-up was
45.5 and 40.7, respectively. Average VAS score at pre-
sentation and follow-up was 73.3 and 50.7, respectively.
However, high functioning at time of presentation had a
more favorable outcome statistically with 48.9%
improvement in pain and continued high functional status.
The authors concluded transforaminal CESI was not indi-
cated in this group except for possibly higher functioning
individuals at presentation.
Slipman et al. [34] retrospectively report only 20% with
good to excellent outcome with mean follow-up of
20.7 month for transforaminal CESI in 15 subjects for
traumatically induced cervical spondylotic radicular pain.
In these subjects with cervical spondylotic foraminal ste-
nosis, symptoms occurred following a traumatic incident.
Motor vehicle accident accounted for 46.7%, fall 13.3%,
lifting injury 20%, and sport injury 20%. The authors
concluded the use of transforaminal CESI is not supported
in this group.
Slipman et al. [35] retrospectively present 20 subjects
that underwent transforaminal CESI for radicular pain due
to non-traumatic cervical spondylotic foraminal stenosis.
Follow-up was done at an average of 21.2 months (range,
12–45 months) with subjects receiving an average of 2.2
injections. Sixty percent had good to excellent results. Pain
decreased from VAS score 6.9 to verbal numeric scale
score of 2.0. There was no significant change in employ-
ment status but significant decrease of medication usage.
Lin et al. [36] retrospectively reported on 70 consecutive
subjects that underwent transforaminal CESI for radicular
pain from a herniated cervical disk. All patients had been
offered surgical treatment but given the option of a trans-
foraminal CESI. Mean follow-up was 13 months (range,
6 months to 4 years) with 65.3% good to excellent relief
with Odom criteria and avoidance of surgery. The authors
found more favorable result in those over age 50 and
symptom duration less than 100 days.
The above observational studies with cervical trans-
foraminal ESI suggest benefit for radicular pain due to
non-traumatic spondylotic stenosis and herniated disk [31,
35, 36]. However the lack of a control group does not
exclude a favorable natural history. The studies also sug-
gested transforaminal CESI is not beneficial in those with
chemical radiculitis or cervical spondylotic foraminal ste-
nosis following a motor vehicle accident [33, 34]. The one
randomized, prospective study was poorly designed [30]. A
validated outcome measure was not utilized. For pain
relief, any pain improvement at the 3 week follow-up was
included. A subject with only 10% relief would be included
in the same group as one with 90% relief. Only short-term
outcome was measured. Also, local anesthetic has anti-
inflammatory effect and improves radicular flow both
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therapeutic benefits. Clinically, patients may receive from
one to four therapeutic injections in a treatment regimen
not just one. Nevertheless, prospective, randomized con-
trolled trials are needed to determine the effectiveness of
CESI in the management of radicular pain from herniated
disk and spondylotic foraminal stenosis.
A randomized controlled trial of perineural injection
was found to be superior to inter-laminar epidural injection
in radiculitis from herniated lumbar disk [37]. A retro-
spective study also found lumbar transforaminal epidural
steroid injections had superior pain reduction than inter-
laminar epidural steroid injections at short term and less
surgical interventions at 1 year review [38]. These studies
support the benefits of target-specific injection. However,
studies of the lumbar spine cannot necessarily be extrap-
olated to the cervical spine. There are currently no
prospective studies in the English literature comparing the
effectiveness of transforaminal versus interlaminar CESI
for specific diagnostic groups.
Complications and side-effects
The decision to proceed with any intervention not only
requires understanding of the benefits but also the risks.
Complications reported with interlaminar cervical epidural
steroid injections include dural puncture, bloating, nausea
and vomiting, vasovagal reaction, facial flushing, fever,
nerve root injury, pneumocephalus, epidural hematoma,
subdural hematoma, stiff neck, Cushing’s syndrome, tran-
sient paresthesias, hypotension, respiratory insufficiency,
transient blindness, epidural abscess, paralysis, cord injury,
and death [39–51].
Complications reported with transforaminal cervical
epidural steroid injections include neck pain, transient
increased radicular pain, nausea, vasovagal reaction, dural
puncture, non-specific headache, transient lightheadedness,
dyspepsia, fluid retention, transient global amnesia, verte-
bral artery injury, paralysis, cord infarction and cerebellar
infarction, and death [52–57].
Blinded and fluoroscopically guided interlaminar CESI
Waldman [58] prospectively reported upon complications
with blind interlaminar C5-6 or C6-7 epidural steroid
injections utilizing loss of resistance technique on 215
subjects receiving 790 injections. Complications were
recorded immediately at 6 weeks by the pain management
physician or nurse. Two individuals suffered dural punc-
ture with headache requiring blood patching. There were 3
vasovagal reactions and one superficial infection.
Botwin et al. [59] retrospectively reported complications
with fluoroscopically guided C6-7 or C7-T1 interlaminar
epidural steroid injections on 157 subjects receiving 345
injections. Data were obtained at 24 h from the ambulatory
surgical center questionnaire and 3 week physician follow-
up. There was 6.7% neck pain, 4.6% non-positional
headache, 1.7% insomnia, 1.7% vasovagal reaction, 1.5%
facial flushing, 0.3% fever, and 0.3% dural puncture inci-
dence. The overall rate of complications was 16.8%.
Fluoroscopically guided transforaminal CESI
Ma et al. [52] reviewed records of 1,036 cervical trans-
foraminal epidural steroid injections in 844 subjects.
Immediate complications were recorded by the radiologist
performing the procedure. If any complications occurred
after discharge, the subjects were told to contact their
referring physician. Hence, complications that occurred
after discharge are at risk of being underreported. The
authors’ report complications occurred in 14 subjects
(1.66%). These included headache/dizziness (0.59%),
transient pain or weakness (0.71%), hypersensitivity reac-
tion (0.12%), transient global amnesia (0.12%), vasovagal
reaction (0.12%), and wrong site injection (0.36%).
Huston et al. [53] performed a prospective, controlled
study with independent interviewer of lumbar and cervical
selective nerve root injections on 151 subjects who
received 306 injections. The control group was 60 subjects
with similar demographics and spinal complaints that
did not undergo an intervention at time of interview.
Procedural complications were recorded by the interven-
tionalist. Immediate, 1 week and 3 month complications
were recorded by an independent interviewer. Of the cer-
vical group, there were 89 cervical selective nerve root
injections performed on 37 subjects. There were no major
complications. There was one dural puncture but the sub-
ject did not develop a headache and no treatment was
needed. In the cervical group immediate complications
were increased pain at injection site 22.7%, increased
radicular pain 18.2%, lightheadedness 13.6%, increased
spine pain 9.1%, non-specific headache 4.5%, and nausea
3.4%. One week follow-up compared to the control group
had significance for increased pain at injection site
(P = .001), non-specific headache (P = .019), and non-
spinal headache (P = .002). At 3 months follow-up 2
subjects complained of increased neck pain. One would
repeat the injections again. The other subject would not
repeat the injection. This subject did have complete reso-
lution of radicular pain from a herniated disk but was not
satisfied because of persistent neck pain.
Interlaminar versus transforaminal CESI
Incidence of dural puncture with interlaminar CESI ranges
from 0.25% to 2.00% [21, 58, 60] and transforaminal CESI
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1.12% [53]. With dural puncture the procedure is discon-
tinued to avoid subarachnoid instillation of local anesthetic
or corticosteroid. Instillation of local anesthesia could
result in spinal anesthesia with respiratory depression,
hypotension, and syncope [61]. Additionally, subarachnoid
corticosteroid injection has been hypothesized to cause
arachnoiditis [62, 63]. Celestone Chronodose has been
evaluated in sheep and found to result in arachnoiditis at
suprapharmacologic levels [64]. Epidural injections of tri-
amcinolone and methyprednisolone in animal studies did
not result in arachnoiditis or nerve root injury [65, 66].
After dural puncture, there is still the concern of spinal
headache. However, dural puncture does not always result
in a spinal headache [53, 58, 60, 61]. If a headache does
occur, treatment may consist of strict bed rest, hydration,
analgesics, and caffeine [67]. For severe or persistent
headache interlaminar or transforaminal blood patching
may be performed [58, 68].
The risk of dural puncture may be higher with an
interlaminar than a transforaminal approach. Cryomicro-
tome studies of the cervical epidural space report absence
of the posterior epidural space above C7-T1. In another
study, the posterior epidural space at C5 has been reported
at 1–1.5 mm [69]. Furthermore, there is an absence of the
interspinous ligament in the cervical spine [69] along with
half of specimens being deficient in the midline of the
ligamentum flavum. Hence, blind injections utilizing loss
of resistance technique may inadvertently puncture the
dura. With transforaminal CESI, utilizing multi-planar
imaging should avoid inadvertent dural puncture. On the
AP view, the needle should not be advanced beyond the 6
o’clock (midline) position of the lateral mass. Dural
puncture typically occurs by advancing the needle too far
in the oblique plane. The technique section will discuss the
need for frequent multi-planar imaging while advancing
the spinal needle.
Non-positional headaches occurred with cervical selec-
tive nerve root injections in 4.5% and was found to be
statistical significant when compared to a control popula-
tion [53]. For fluoroscopically guided interlaminar CESI,
non-positional headache occurred in 4.6%. The rate is
comparable between the two techniques. These headaches
have been attributed to alterations in CSF pressure which is
related to rapid injection and/or higher volumes [70, 71].
These headaches are typically transient and respond to oral
analgesics. These headaches can be minimized by injecting
slowly and the use of lower volumes.
Transient blindness after epidural steroid injection has
been reported primarily with lumbar interlaminar and
caudal injections. However, Kao [47] reported a case of
impaired visual acuity following a C6-7 interlaminar ESI
with 4 ml lidocaine and 2 ml triamcinolone. Five days
after the second CESI, the patient developed headache,
vomiting, neck stiffness, and decreased left visual acuity. A
serous retinal detachment was found. The detachment
resolved after 4 weeks but still with impaired vision. By 4
months, the patient reported normal vision. The cause of
the retinal detachment is unknown. The author hypothe-
sizes the following possibilities: (1) stress during the
injection resulted in neuroendocrine alteration, (2) corti-
costeroid may have damaged the choroicapillaris with
altered permeability, and (3) the corticosteroids may have
elevated cathecholamine levels resulting in constriction of
choroids vessels. If due to the steroids, then any utilization
of corticosteroid whether oral, intra-muscular, or epidural
with systemic absorption could potentially result in retinal
detachment. Another possibility is increased CSF pressures
which could explain the headache and vomiting the patient
experienced. While the volume was 6 ml, rapid instillation
could increase CSF pressures.
Bilateral retinal hemorrhages with transient blindness
after caudal and lumbar ESI has been reported [72–75].
The retinal hemorrhages were felt to be related to increased
CSF pressure created by rapid instillation and large vol-
umes of medication injected with ESI [72, 73]. Volumes of
20 ml can increase CSF pressures [72]. Volumes of lido-
caine and bupivicaine have ranged from 2 to 20 ml with
cervical interlaminar ESI [21, 58, 76]. Larger volume
CESI’s with rapid instillation should be avoided.
Cushing’s syndrome has been reported after interlami-
nar CESI with 60 mg of methylprednisolone [45]. The
syndrome resolved after 12 months. Cushing’s syndrome
has also been reported after lumbar ESI. While Cushing’s
syndrome has not been reported with transforaminal ESI,
the occurrence is probably related to the systemic absorp-
tion of the corticosteroid as opposed to the technique of
delivery. Additionally, systemic affects of corticosteroids
can result in hyperglycemia in diabetics and needs to be
closely monitored.
Infection is always a risk whenever the skin is punc-
tured. Huang et al. [51] present a case of epidural abscess
following CESI. The patient initially presented with
increased neck pain and chills. The patient subsequently
developed left arm pain, paresthesia, and weakness but was
neurologically intact in the lower extremities. An epidural
abscess from C4 to C6 was seen on gadolinium-enhanced
MRI. The patient underwent surgical decompression, irri-
gation, and debridement. The patient was placed on
intravenous antibiotics. By 7 months post-operative, the
patient regained baseline neurologic function [51]. Whe-
ther one technique is more predisposed is unknown. The
procedure should be done with sterile technique. Addi-
tionally, the interventionalist should not touch the spinal
needle tip. Both techniques are at risk for infection.
Nerve root injury and transient paresthesias have been
reported after interlaminar CESI [46, 60]. After a blind
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interlaminar C5-6 ESI, nerve root injury was postulated as
the initial injury resulting in complex regional pain syn-
drome [50]. For cervical selective nerve root injections
transient increased radicular pain occurred in 18.2% but
with no episodes of nerve root injury [53].
Paralysis: interlaminar and transforaminal CESI
Epidural hematoma after fluoroscopically guided C5-6
interlaminar CESI requiring surgical evacuation has been
reported [42]. The patient had near full recovery of paral-
ysis. Another case occurred within half and hour after
painful paresthesia with the introduction to a Touhy needle
at the C6-7 interspace [43]. The patient had incomplete
recovery prior to surgery with high-dose intravenous
methylprednisolone. The patient also required immediate
surgical evacuation of the hematoma. Puncturing of the
epidural venous plexus is the probable etiology. Whether
the risk of epidural hematoma and subsequent quadriplegia
is greater with interlaminar versus transforaminal CESI is
unknown. However, with tranforaminal injections the
needle is not placed directly into the spinal canal. Punc-
turing a radicular vein or artery within the foramen may be
less likely to result in thrombosis formation with cord
compression as the needle is not within the spinal canal.
However, there may be other serious consequences of
vascular puncture with transforaminal injections.
Brouwers [54] reported a case of tetraplegia following a
right C6 transforaminal ESI with bupivicaine/triamcino-
lone mixture. The paralysis was consistent with anterior
spinal artery syndrome. Another case was reported of cord
infarction after left C6 transforaminal ESI with the patient
suffering incomplete tetraplegia [56]. In another case,
digital subtraction revealed puncture of a radicular artery
terminating with several branches in the region of the
spinal cord despite correct technique with a transforaminal
cervical epidural injection [77]. The procedure was done
with live fluoroscopy when injecting contrast. Fortunately,
the procedure was abandoned without sequelae after noting
the vascular flow. Tiso et al. [57] reported a case of cere-
bellar infarction after a C6 transforaminal CESI with
bupivicaine/triamcinolone mixture. Intra-vascular injection
of particulate steroid resulting in embolic occlusion
through the vertebral artery with subsequent infarction was
postulated as the cause. Pathology revealed bilateral cere-
bellar and occipital cortex infarction, thromboembolism of
the leptomeningeal artery.
Light microscopy of steroid particulate size found up to
50 lm particle size for methylprednisolone, triamcinolone,
betamethasone sodium phosphate and acetate, dexametha-
sone, and betamethasone sodium phosphate [57]. Only
betamethasone sodium phosphate had no particles greater
than 50 lm. Less than 5% of particles were greater than
50 lm for methylprednisolone, betamethasone sodium
phosphate and acetate, and dexamethasone. Methylpred-
nisolone and triamcinolone had a tendency to coalesce into
large aggregates of greater than 100 lm, which could result
in sludging [57]. Particle and aggregate size is relevant
when one considers the diameter of the artery system:
artery [50 lm, metarteriole 20–50 lm, arteriole 10–
15 lm, and capillary 5–8 lm. Based upon dimensions,
methylprednisolone and triamcinolone sludge could block
smaller arteries and arterioles and result in ischemia [57].
Dexamethasone and betamethasone sodium phosphate
would be better choices to avoid vascular occlusion. How-
ever, betamethasone sodium phosphate is not available
commercially. While betamethasone sodium phosphate can
be obtained through a compounding pharmacy, it is not
recommended. Meningitis with subsequent death has
been linked to compounding pharmacies making beta-
methasone sodium phosphate [78]. Hence, at this time, the
corticosteroid recommended for transforaminal CESI is
commercially available dexamethasone [57]. Furthermore,
there was no statistical significance difference between
outcomes with dexamethasone versus triamcinolone for
cervical radicular pain [79].
Temporary paralysis was reported after a diagnostic C7
transforaminal injection with 0.8 ml 2% lidocaine [80].
Sixty-seconds after injection the patient felt unwell. In the
next 2–3 min the patient developed quadraparesis that
resolved after 20 min. The neurologic deficits were con-
sistent with anterior spinal artery syndrome. The authors
recommend injecting local anesthetic first and separate
from the steroid [80].
The current hypothesis of tetraplegia following trans-
foraminal epidural steroid injection relates to arterial
injection of corticosteroid into a radiculomedullary artery
with subsequent occlusion. The radiculomedullary arteries
are major feeders to the anterior spinal artery. These
arteries can arise anywhere from C3 to C8. Occlusion of a
radiculomedullary artery can result in spinal cord infarc-
tion—anterior spinal artery syndrome. While vertebral
artery puncture should be avoided by adhering to correct
technique, Baker et al. [77] demonstrated a correct tech-
nique which can still result in injection into a radicular
artery. When performing a transforaminal CESI, the fol-
lowing are modified recommendations to minimize the
chance of radicular artery injection of corticosteroid [77]:
(1) once the needle is in place, tubing should be connected
to the spinal needle hub and syringe. This is to prevent
inadvertent needle movement when attaching different
syringes of injectate. (2) Injection of contrast under live
fluoroscopy—evaluating for any vascular flow. Digital
subtraction imaging may be of benefit. [3] If no vascular
flow with contrast, then proceed to injection of local
anesthetic under live fluoroscopy. The patient is then
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monitored for at least 90 s. This is based upon the case
report of Karasek and Bogduk [80] in which initial
symptoms of radicular artery injection of local anesthetic
occurred at 1 min and paralysis in 2 min. After the time
interval expires, the patient should be asked about a
metallic taste, peri-oral numbness, auditory changes, agi-
tation suggesting local anesthetic toxicity. Additionally
pin-prick is tested in the hands and lower extremities along
with movement of the hands and feet. If no signs are
present to suggest anterior spinal artery syndrome or intra-
arterial injection, then proceed to step 4. (4) Before
injecting dexamethasone, confirm needle placement has not
changed utilizing fluoroscopy. Then slowly inject
dexamethasone.
The occurrence of tetraplegia has opened the debate of
whether transforaminal or interlaminar CESI should be
performed. However, tetraplegia has occurred after inter-
laminar CESI. Cord injury following two cases of
fluoroscopically guided interlaminar C5-6 ESI occurred in
sedated patients [81]. The authors suggested the sedation
did not allow the patients to respond to cord penetration by
the needle. However, needle penetration of the cord in alert
patients can be without pain or paresthesias [82]. While
cord puncture may not be painful, injection of contrast
agent into the cord produced pain [83]. Tetraplegia fol-
lowed a fluoroscopically guided C6-7 interlaminar ESI
[84]. While the cause is unknown, the authors hypothesized
ischemic injury to the cord [84]. Bromage and Benumof
reported a case of paralysis consistent with anterior artery
syndrome in an individual undergoing spinal epidural
anesthesia at T12 [85]. While the cause was unknown, the
case report raised caution in epidural injections performed
above the termination of the cord [85].
The cord is at risk of puncture with interlaminar CESI.
The ligamentum flavum in the cervical region was found to
be deficient in the midline in half of specimens [69]. Fur-
thermore, the interspinous ligament is absent in the cervical
spine [69]. When utilizing a loss of resistance technique,
lack of resistance from absence of the interspinous liga-
ment and unfused ligamentum flavum could lead to
inadvertent dural and cord puncture. Performing the pro-
cedure under fluoroscopic guidance should help avoid
inadvertent cord penetration.
Both interlaminar and transforaminal CESI’s have case
reports of catastrophic neurologic complications and death.
The incidence of these complications while felt to be rare is
unknown. Derby et al. [86] surveyed instructors of the
International Spine Intervention Society. While not scien-
tific, the survey revealed no major complication, no
paralysis or death, in 4,389 interlaminar and 1,579 trans-
foraminal injections. A national databank of complications
would be helpful in determining the incidence of rare
complications. This would be helpful in developing safer
techniques and in appropriate consenting of patients
undergoing CESI’s. This system would be beneficial for
the continuous improvement of patient care. Unfortunately,
the current medical malpractice legal climate in the United
States creates challenges in developing such a system.
Technique
Advanced imaging with magnetic resonance imaging
(MRI) or at least multi-planar computed tomography
should be obtained before proceeding with spinal inter-
ventions, including cervical epidural injections. Cervical
spine MRI can determine the cause of radicular pain—
herniated disk or cervical foraminal stenosis. If not diag-
nostic, further testing may be required—electrodiagnostic
studies, diagnostic selective nerve root injections, brachial
plexus MRI [87]. Knowing the cause of radicular pain will
help determine the benefit of a cervical epidural injection.
This is important in obtaining informed consent from the
patient. Furthermore, one can plan the procedure noting
any anatomic variances that may affect the procedure. The
vertebral artery path can be followed to evaluate for a
tortuous vertebral artery overlying a foramen that may
interfere with a transforaminal injection. A tortuous ver-
tebral artery in the C4-5 foramen compressing the C5 nerve
root resulting in radicular symptoms has been reported
[88]. Magnetic resonance angiogram (MRA) identified the
tortuous artery [88]. Obviously, attempt at a transforaminal
CESI in that case could have potentially resulted in cere-
bral vascular accident and death [55]. Central stenosis or
posterior displacement of the cord reducing or obliterating
the posterior epidural space at the level of a planned
interlaminar cervical epidural injection places the cord at
risk of puncture.
If a patient develops complications post-injection, a pre-
procedure MRI is very helpful to compare to a new MRI
for any changes. Is the cystic structure seen on MRI a
synovial cyst or abscess? Are the endplate changes Modic
type I degenerative endplate changes or suggestions of
osteomyelitis with marrow edema? A pre-procedure MRI
would easily answer these questions.
Anatomy
Understanding cervical spine anatomy is imperative to the
interventionalist performing cervical spine procedures. The
epidural space is a triangular space extending from the
foramen magnum to the sacral hiatus. The inner border is
the thecal sac—dura mater. The outer border is the bony
spinal canal and the covering periosteum. The anterior
border is the posterior longitudinal ligament. The posterior
border is the lamina and ligamentum flavum. The lateral
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border is the pedicle and intervertebral foramen. The epi-
dural space contains loose areolar tissue, venous plexus,
spinal nerve roots, radicular arteries, superficial and deep
cervical arteries, arachnoid granules, and lymphatics.
Above C7-T1 no posterior epidural space was evident on
study [69]. The ligamentum flavum is unfused in the
midline in approximately half of individuals and the
interspinous ligament is absent [69].
Rootlets arise from the cord to form ventral and dorsal
nerve roots which exit with the thecal sac covered with
dura—the root sleeve. The dura ends at the proximal
margin of the dorsal root ganglion. The ventral and dorsal
roots coalesce to form the spinal nerve that exits from the
foramen. The dura extends as the epiradicular sheath
covering the dorsal root ganglion and spinal nerve. The
spinal nerve is located in the inferior aspect of the foramen.
The foramen is formed by the superior and inferior
pedicle. The superior articular process of the zygapophy-
seal joint forms the posterior wall. The anterior wall is
superior vertebral endplate and disk.
The spinal nerve is posterior to the vertebral artery [89].
The vertebral artery arises from the subclavian and enters the
costotransverse foramen at C6 and exits at C1 but can enter
at C5 [90]. The vertebral artery crosses posterior to C1 arch
before entering the skull through the foramen magnum.
Branches from the vertebral artery descend forming the
anterior spinal artery. The anterior spinal artery is divided
into cervical, thoracic, and lumbar segments [89]. Spinal
arteries arising from the vertebral, subclavian, and ascend-
ing cervical and deep cervical arteries enter through the
foramen and divide into the anterior and posterior cervical
radicular arteries [90]. Most radicular arteries supply the
nerve root. A variable number of anterior radicular arteries
supply the anterior spinal artery. These radicullomedullary
arteries are larger and may ascend and descend within the
thecal sac supplying the anterior spinal artery. In the cervical
region a variable number of radicullomedullary arteries are
present and may enter anywhere from C3 to C8 [91, 92] The
radicular arteries and radicullomedullary arteries may be
located posterior to the spinal nerve in the posterior-inferior
aspect of the foramen, close to the target zone of transfora-
minal injections [90].
Interlaminar CESI
The patient is placed in a prone position on the fluoroscopy
table with arms at the side. A blanket is placed under the
chest. The neck is flexed with the head resting on a folded
towel or blanket. To help prevent movement the head may
be held in place with a Velcro strap though not all practi-
tioners do this. The neck is prepped and draped in the usual
sterile manner and sterile technique is utilized throughout
the procedure. AP view is obtained to ensure the C7-T1
interspace located and the patient is correctly positioned in a
true AP view. A skin wheal is raised with a 10:1 mixture of
1% lidocaine and 8.4% bicarbonate. A 20–22 gauge Touhy
needle is directed in the midline with a tunnel view parallel
to the trajectory of the spinous processes. Once purchase of
the needle in the paraspinal muscles occurs, a lateral view is
obtained. A syringe containing normal saline is attached to
the Touhy needle. Maintaining the same trajectory, the
needle is advanced in the lateral plane checking for loss of
resistance. The needle should not be advanced beyond the
spinolaminar line. Advancing beyond this line risks dural
and cord puncture. Additionally, loss of resistance may not
occur despite entering the epidural space [93]. If the patient
develops pain or paresthesias suggesting cord puncture or
nerve root puncture, the needle should be withdrawn and the
procedure abandoned. Contrast should not be injected as
intra-cord instillation could be catastrophic [81]. More
specifically, if cord puncture occurred, then dural puncture
also occurred. Once loss of resistance occurs or the needle
tip is at the spinolaminar line, needle advancement should
stop. Position of the needle is checked in both the AP and
lateral plane to ensure the needle is midline and at or only
slightly beyond the spinolaminar line. A syringe contained
non-ionic contrast (Isovue or Omnipaque) is attached to low
volume extension tubing and flushed. Prior to attaching the
extension tubing, a drop of contrast is placed in the Touhy
needle to flush out any air. Then under live fluoroscopy
contrast is injected evaluating for epidural flow and ensuring
no vascular pattern. If a venous pattern occurs, the needle is
withdrawn and repositioned. If an arterial pattern occurs, the
procedure should be abandoned. If a myelographic pattern is
obtained indicating subarachnoid injection, the procedure is
abandoned [93]. Contrast should flow epidurally along the
spinolaminar line creating a dorsal stripe [94]. Then under
live fluoroscopy 2 cc of 1% lidocaine and 2 cc Dexameth-
asone is slowly infused. While the risk of radicular artery
cannulation is probably lower for interlaminar injection, one
may err on the side of caution and inject local anesthetic and
steroid separately.
Transforaminal CESI
The patient is placed in the supine-oblique position on the
fluoroscopy table. A towel or blanket is placed under the
head to keep the neck parallel to the table. The patient is
rolled into the correct position with the foramen perpen-
dicular to the radiographic imager. A bolster is then placed
behind the patient to support this position. The patient is
prepped and draped in a sterile fashion and sterile tech-
nique is utilized throughout the procedure. Before starting,
the interventionalist should review the image to visualize
the target and path of the needle. One should visualize the
path of the vertebral artery on the fluoroscopic image. If the
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patient’s position is too oblique, the vertebral artery may be
in the path of the needle. If too lateral, attempts to advance
the needle into the foramen will result in anterior place-
ment of the needle, risking vertebral artery puncture.
Proper patient positioning is paramount. Once correctly
positioned, a skin wheal is raised with 10:1 mixture of 1%
lidocaine and 8.4% bicarbonate. A 22 gauge 1.5–2.5 inch
spinal needle is advanced parallel to the radiographic beam
to abut upon the mid-portion near the anterior edge of the
superior articular process to gauge depth. The needle is
slightly withdrawn and then redirected into the posterior
aspect of the foramen 1–2 mm. The position is checked in
the AP plane, the needle tip should be slightly beyond the
lateral border of the cervical pillar. The needle is then
advanced 1–2 mm in the AP plane. If nerve is contacted,
the patient typically experiences pain or paresthesia into
the scapula or upper extremity. The needle should be
slightly withdrawn off the nerve. The needle should not be
advanced beyond the mid-sagittal line of the lateral mass.
Oblique and lateral views are checked to ensure the needle
is in the posterior aspect of the foramen [52]. A 1 cc syr-
inge containing non-ionic contrast (Isovue or Omnipaque)
is connected to low volume extension tubing and flushed
with contrast. The extension tubing is then connected to the
spinal needle hub after first providing a drop of contrast
into the spinal needle to flush out any air. The extension
tubing minimizes the chance of needle movement with
attaching and detaching the various syringes. Furthermore,
the tubing keeps the interventionalist’s hand away from the
fluoroscopic beam. Contrast 0.5–1.0 cc is then infused
under live fluoroscopy carefully evaluating not only for
outline of the nerve root but also for any vascular flow. If
arterial flow is obtained the procedure is abandoned. If a
myelographic pattern is obtained—dural puncture with
subarachnoid injection—the procedure is abandoned. If
venous flow is obtained, the needle is withdrawn back upon
the superior articular process. The needle is then redirected
into a different region of the foramen keeping the needle in
the posterior half of the foramen—away from the vertebral
artery. Multi-planar fluoroscopic imaging of needle place-
ment is performed before infusion of contrast. Contrast
should outline the nerve root with epidural flow and no
vascular pattern. Digital subtraction imaging has been
recommended but not required [77]. Preservative free 1%
xylocaine 0.5–1.0 cc is then instilled under live fluoros-
copy carefully watching for any vascular flow. After 90 s,
the patient is queried about peri-oral numbness, metallic
taste, tinnitus, light-headedness, shortness of breath, and
agitation. The patient is asked to move the fingers and toes,
and pin-prick is tested on the hands and lower legs or feet.
If there are no untoward effects, 1.0–1.5 cc dexamethasone
may then be infused slowly. Before injecting, imaging is
performed to ensure the needle position has not changed.
Sedation
Most patients do not require any sedation. For those who
are very anxious, needle-phobic, vasovagal tendency, poor
tolerance to pain or the procedure; intravenous minimal to
moderate sedation may be performed. However, the patient
still needs to be responsive to voice commands and have
their protective mechanisms intact. More specifically, the
patient should be able to respond with pain to needle
touching nerve root or cord. As previously mentioned cord
penetration may be asymptomatic. However, cord injection
can be painful and the patient should be awake enough to
respond to such an occurrence. The goal of moderate
sedation is allow the patient to tolerate the procedure such
that the procedure can be performed safely and without
endangering the patient.
Conclusion
Cervical epidural steroid injections are frequently utilized
in the treatment of cervical radicular pain. Pathophysio-
logic studies of cervical disk herniation support the
utilization of corticosteroids. Observational studies are also
supportive of cervical epidural injections in the manage-
ment of cervical disk herniation and atraumatic cervical
spondylotic foraminal stenosis. However, prospective,
randomized controlled studies are needed. Transforaminal
CESI’s have been postulated to be more effective than
interlaminar CESI’s based upon accurate delivery of
medication to the site of pathology. However, prospective
studies are needed to compare the techniques. Both pro-
cedures have the potential for catastrophic complications.
Whether one technique is safer than another is unknown.
By utilizing impeccable technique complications can be
minimized. Both procedures should be performed under
fluoroscopy to reduce risk of serious complications and to
ensure appropriate delivery of medication into the epidural
space. The change to live fluoroscopy, separate injections
of anesthetic and steroid, and the change to dexamethasone
will hopefully minimize or eliminate the cases of anterior
spinal artery syndrome following transforaminal CESI.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Radhakrishnan K, Litchy WJ, O’Fallon WM, Kurland LT. Epi-
demiology of cervical radiculopathy: a population-based study of
Rochester, Minnesota, 1976–1990. Brain. 1994;117:325–35.
Curr Rev Musculoskelet Med (2009) 2:30–42 39
2. Sampath P, Bendebba M, Davis JD, Ducker T. Outcome in
patients with cervical radiculopathy. Prospective, multicenter
study with independent clinical review. Spine. 1999;24(6):591–7.
3. Heckmann JG, Lang CJG, Zobelein I, Laumer R, et al. Herniated
cervical intervertebral discs with radiculopathy: an outcome
study of conservatively or surgically treated patients. J Spinal
Disord. 1999;12:396–401.
4. Maigne JY, Deligne L. Computed tomographic follow-up study
of 21 cases of nonoperatively treated cervical intervertebral soft
disc herniation. Spine. 1994;19:189–91.
5. Bush K, Chaudhuri R, Hillier S, Penny J. The pathomorphologic
changes that accompany the resolution of cervical radiculopathy:
a prospective study with repeat magnetic resonance imaging.
Spine. 1997;22:183–6.
6. Kang JD, Georgescu LML, Stefanovic-Racic M, Evans CH.
Herniated cervical intervertebral discs spontaneously produce
matrix metalloproteinases, nitric oxide, interleukin-6, and pros-
taglandin E2. Spine. 1995;20:2373–8.
7. Furusawa N, Baba H, Miyoshi N, Maezawa Y, et al. Herniation
of cervical intervertebral disc. Immunohistochemical examina-
tion and measurement of nitric oxide production. Spine. 2001;26:
1110–6.
8. Frans RC, saal JS, Saal JA. Human disc phopholipase A2 is
inflammatory. Spine. 1992;17:S129–32.
9. Osaktay AC, Cavanaugh JM, Blagoev DC, King AI. Phospholi-
pase A2 induced electrophysiologic and histologic changes in
rabbit dorsal lumbar spine tissues. Spine. 1995;20:2659–68.
10. Lee HM, Weinstein JN, Meller ST, Hayashi N, et al. The role of
steroids and their effects on phospholipase A2: an animal model
of radiculopathy. Spine. 1998;23:1191–6.
11. Olmarker K, Byrod G, Cornefjord M, et al. Effects of methyl-
prednisolone on nucleus pulposus-induced nerve root injury.
Spine. 1994;19:1803–8.
12. Slipman CW, Huston CW, Shin C. Diagnostic and therapeutic
injections. In: Gonzalez EG, Myers SJ, Edelstein JE, Lieberman
JS, Downey JA, editors. Downey & Darling’s physiological basis
of rehabilitation medicine. Boston: Butterworth Heinemann;
2001. p. 795–813.
13. Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress
ectopic neural discharge originating in experimental neuromas.
Pain. 1985;22:127–37.
14. Hall ED. Glucocorticoid effect on central nervous excitability and
synaptic transmission. Int Rev Neurobiol. 1982;23:165–95.
15. Hall ED. Acute effects of intravenous glucocorticoid on cat spinal
motor neuron electrical properties. Brain Res. 1982;240:186–90.
16. Johansson A, Hao J, Sjolund B. Local corticosteroid application
blocks transmission in normal nociceptive C-fibres. Acta Ana-
esthesiol Scand. 1990;34:335–8.
17. Shoji Y, Kawaguchi Y, Nordborg C, Kikuchi S, et al. Effects of
lidocaine on nucleus pulposus-induced nerve root injury: a neu-
rophysiologic and histologic study of the pig cauda equine. Spine.
1998;23:2383–9.
18. Yabuki S, Kikuchi S. Nerve root infiltration and sympathetic
block. An experimental study of intraradicular blood flow. Spine.
1995;20:901–6.
19. Rowlingson JC, Kirschenbaum LP. Epidural analgesic techniques in
the management of cervical pain. Anesth Analg. 1986;65:938–42.
20. Mangar D, Thomas PS. Epidural steroid injections in the treat-
ment of cervical and lumbar pain syndromes. Reg Anesthesia.
1991;16:246.
21. Ferrante FM, Wilson SP, Iacobo C, Orav EJ, et al. Clinical
classification as a predictor of therapeutic outcome after cervical
epidural steroid injection. Spine. 1993;18:730–6.
22. Stav A, Ovadia L, Sternberg A, Kaadan M, et al. Cervical epi-
dural steroid injection for cervicobrachialgia. Acta Anaesthesiol
Scand. 1993;37:562–6.
23. Marshall LL, Trewhewie ER, Curtain CC. Chemical radiculitis.
Clin Orthop Relat Res. 1977;129:68–71.
24. Castagnera L, Maurette P, Pointillart V, Vital JM, et al. Long-
term results of cervical epidural steroid injection with and with-
out morphine in chronic cervical radicular pain. Pain.
1994;58:239–43.
25. Grenier B, Castagnera L, Maurette P, Erny P, et al. Nevralgie
cervico-brachiale chronique traitee par injection peridurale cer-
vicale de corticoids. Resultants a long terme. Ann Fr Anesth
Reanim. 1995;14:484–8.
26. Stojanovic MP, Vu TN, Caneris O, Slezak J, et al. The role of
fluoroscopy in cervical epidural steroid injections: an analysis of
contrast dispersal patterns. Spine. 2002;27:509–14.
27. Bush K, Hillier S. Outcome of cervical radiculopathy treated with
periradicular/epidural corticosteroid injections: a prospective study
with independent clinical review. Eur Spine J. 1996;5:319–25.
28. Saal JS, Saal JA, Yurth EF. Nonoperative management of her-
niated cervical intervertebral disc with radiculopathy. Spine.
1996;21:1877–83.
29. Goel A, Pollan J. Contrast flow characteristics in the cervical
epidural space. An analysis of cervical epidurograms. Spine.
2006;31:1576–9.
30. Anderberg L, Annertz M, Persson L, Brandt L, et al. Transfora-
minal steroid injections for the treatment of cervical
radiculopathy: a prospective and randomized study. Eur Spine J
2007;16:321–8.
31. Vallee JN, Feydy A, Carlier RY, Mutschler C, et al. Chronic
cervical radiculpathy: lateral-approach periradicular corticoste-
roid injection. Radiology. 2001;218:886–92.
32. Cyteval C, Thomas E, Decoux E, Sarrabere MP, et al. Cervical
radiculopathy: open study on percutaneous periradicular forami-
nal steroid infiltration performed under CT control in 30 patients.
Am J Neuroradiol. 2004;25:441–5.
33. Slipman CW, Lipetz JS, Jackson HB, Plastaras CT, et al. Out-
comes of therapeutic selective nerve root blocks for whiplash
induced cervical radicular pain. Pain Physician. 2001;4:167–74.
34. Slipman CW, Lipetz JS, DePalma MJ, Jackson HB. Therapeutic
selective nerve root block in the nonsurgical treatment of trau-
matically induced cervical spondylotic radicular pain. Am J Phys
Med Rehabil. 2004;83:446–54.
35. Slipman CW, Lipetz JS, Jackson HB, Rogers DP, et al. Thera-
peutic selective nerve root block in the nonsurgical treatment of
atraumatic cervical spondylotic radicular pain: a retrospective
analysis with independent clinical review. Arch Phys Med
Rehabil. 2000;81:741–6.
36. Lin EL, Lieu V, Halevi L, Shamie AN, et al. Cervical epidural
steroid injections for symptomatic disc herniations. J Spinal
Disord Tech. 2006;19:183–6.
37. Kraemer J, Ludwig J, Bickert U, et al. Lumbar epidural peri-
neural injections: a new technique. Eur Spine J. 1997;6:357–61.
38. Schaufele MK, Hatch L, Jones W. Interlaminar versus transfora-
minal epidural injections for the treatment of symptomatic lumbar
intervertebral disc herniations. Pain Physician. 2006;9:361–6.
39. Purkis IE. Cervical epidural steroids. Pain Clinic. 1986;1:3–7.
40. Simopoulos T, Peeters-Asdourian C. Pneumocephalus after cer-
vical epidural steroid injection. Case report. Anesth Analg.
2001;92:1576–7.
41. Williams KN, Jackowski A, Evans PJD. Epidural haematoma
requiring surgical decompression following repeated cervical
epidural steroid injections for chronic pain. Pain. 1990;42:197–9.
42. Stoll A, Sanchez M. Epidural hematoma after epidural block:
implication for its use in pain management. Surg Neurol. 2002;
57:235–40.
43. Ghaly RF. Recovery after high-dose methylprednisolone and
delayed evacuation: a case of spinal epidural hematoma. J Neu-
rosurg Anesthesiol. 2001;13:323–8.
40 Curr Rev Musculoskelet Med (2009) 2:30–42
44. National Health and Medical Research Council. Epidural use of
steroids in the management of back pain. Commonwealth of
Australia 1994.
45. Tuel SM, Meythaler JM, Cross LL. Cushing’s syndrome from
epidural methylprednisolone. Pain. 1990;40:81–4.
46. Catchlove RFH, Braha R. Clinical reports: the use of cervical
blocks in the management of chronic head and neck pain. Can
Anaesth Soc J. 1984;31:188–91.
47. Kao LY. Bilateral serous retinal detachment resembling central
seroud chorioretinopathy following epidural steroid injection.
Retina. 1998;18:479–81.
48. Field J, Rathmell JP, Stephenson JH, Katz NP. Neuropathic pain
following cervical epidural steroid injection. Anesthesiology.
2000;93:885–8.
49. Reitman CA, Watters W. Subdural hematoma after cervical
epidural steroid injection. Spine. 2002;27:E174–6.
50. Siegfried RN. Development of complex regional pain syndrome
after a cervical epidural steroid injection. Anesthesiology 1997;
86:1394–96.
51. Huang RC, Shapiro GS, Lim M, Sandhu HS, et al. Cervical
epidural abscess after epidural steroid injection. Spine. 2003;
29:E7–9.
52. Ma DJ, Gilila LA, Riew KD. Complications of fluoroscopically
guided extraforaminal cervical nerve blocks: an analysis of 1036
injections. J Bone Joint Surg. 2005;87-A:1025–30.
53. Huston CW, Slipman CW, Garvin C. Complications and side
effect of cervical and lumbosacral selective nerve root injections.
Arch Phys Med Rehabil. 2005;86:277–83.
54. Brouwers PJAM, Kottink EJBL, Dimone MAM, Prevo RL. A
cervical anterior spinal artery syndrome after diagnostic blockade
of the right C6-nerve root. Pain. 2001;91:397–9.
55. Rozin L, Rozin R, Koehler SA, et al. Death during transforaminal
epidural steroid nerve root block(C7) due to perforation of the left
vertebral artery. Am J Forensic Med Pathol. 2003;24:351–5.
56. Ludwig MA, Burns SP. Spinal cord infarction following cervical
transforaminal epidural injection. Spine. 2005;30:E266–8.
57. Tiso RL, Cutler T, Catania JA, Whalen K. Adverse central ner-
vous system sequelae after selective transforaminal block: the
role of corticosteroids. Spine J. 2004;4:468–74.
58. Waldman SD. Complications of cervical epidural nerve blocks
with steroids: a prospective study of 790 consecutive blocks. Reg
Anesth. 1989;14:149–51.
59. Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, et al.
Complications of fluoroscopically guided transforaminal lumbar
epidural injections. Arch Phys Med Rehabil. 2000;81:1045–50.
60. Cicala RS, Westbrook L, Angel JJ. Side effects and complica-
tions of cervical epidural steroid injections. J Pain Symptom
Manage. 1989;4:64–6.
61. Jurmand SH. Corticotherapie peridurale des lombalgies et des
sciatiques f’origine discale. EPU Rhum. 1972;24:5061–70.
62. Bernat JL. Intraspinal steroid therapy. Neurology. 1981;31:168–71.
63. Nelson DA. Dangers from methylprednisolone acetate therapy by
intraspinal injection. Arch Neurol. 1988;45:804–6.
64. Latham JM, Fraser RD, Moore RJ, Blumbergs PC, et al. The
pathologic effects of intrathecal betamethasone. Spine. 1997;22:
1558–62.
65. Cicala RS, Turner R, Moran E, Henley R, et al. Methylprednis-
olone acetate does not cause inflammatory changes in the
epidural space. Anesthesiology. 1990;72:556–8.
66. Delaney TJ, Rowlingson JC, Carron H, Butler A. Epidural steroid
effects on nerves and meninges. Anesth Analg. 1980;59:610–4.
67. Raskin NH. Lumbar puncture headache: a review. Headache.
1990;30:197–200.
68. Slipman CW, El Abd OH, Bhargava A, De Palma MJ, et al.
Transforaminal cervical blood patch for the treatment of post-dural
puncture headache. Am J Phys Med Rehabil. 2005;84:76–80.
69. Hogan QH. Epidural anatomy examined by cryomicrotome sec-
tion. Reg Anesth. 1996;21:395–406.
70. Goebert HW, Jallo SJ, Wasmuth CE. Painful radiculopathy
treated with epidural injections of procaine and hydrocortisone
acetate: results in 113 patients. Anesth Analg. 1961;40:130–4.
71. Burn JMB, Langdon L. Lumbar epidural injections for the
treatment of chronic sciatica. Rheumatol Phys Med.
1970;10:368–74.
72. Ling C, Atkinson PL, Munton CGF. Bilateral retinal haemor-
rhages following epidural injection. Br J Ophthalmol. 1993;77:
316–7.
73. Purdy EP, Ajimal GS. Vision loss after lumbar epidural steroid
injection. Anesth Analg. 1998;86:119–22.
74. Kushner FH, Olson JC. Retinal hemorrhage as a consequence of
epidural steroid injection. Arch Ophthalmol. 1995;113:309–13.
75. Young WF. Transient blindness after lumbar epidural steroid
injection. A case report and literature review. Spine. 2002;27:
E476–7.
76. Shulman M. Treatment of neck pain with cervical epidural steroid
injection. Reg Anesth. 1986;11:92–4.
77. Baker R, Dreyfuss P, Mercer S, Bogduk N. Cervical transfora-
minal injection of corticosteroids into a radicular artery: a
possible mechanism for spinal cord injury. Pain. 2003;103:211–5.
78. Traynor K. Meningitis deaths linked to drug shortage. ASHP
News, July 17, 2001.
79. Dreyfuss P, Baker R, Bogduk N. Comparative effectiveness of
cervical transforaminal injections with particulate and nonpar-
ticulate corticosteroid preparations for cervical radicular pain.
Pain Med. 2006;7:237–42.
80. Karasek M, Bogduk N. Temporary neurologic deficit after cer-
vical transforaminal injection of local anesthetic. Pain Med.
2004;5:202–5.
81. Hodges SD, Castleberg RL, Miller T, Ward R, et al. Cervical
epidural steroid injection with intrinsic spinal cord damage: two
case reports. Spine. 1998;23:2137–40.
82. Pounder D, Elliott S. An awake patient may not detect spinal cord
puncture. Anaesthesia. 2000;55:194.
83. Servo A, Laasonen EM. Accidental introduction of contrast
medium into the cervical spinal cord. A case report. Neuroradi-
ology. 1985;27:80–2.
84. Bose B. Quariparesis following cervical epidural steroid injec-
tions: case report and review of the literature. Spine J. 2005;5:
558–63.
85. Bromage PR, Benumof JL. Paraplegia following intracord
injection during attemped epidural anesthesia under general
anesthesia. Reg Anesth Pain Med. 1998;23:104–7.
86. Derby R, Lee SH, Kim BJ, Chen Y, et al. Complications fol-
lowing cervical epidurals steroid injections by expert
interventionalists in 2003. Pain Physician. 2004;7:445–9.
87. Huston CW, Slipman CW. Diagnostic selective nerve root
blocks: indications and usefulness. Phys Med Rehabil Clin N Am.
2002;13:545–65.
88. Korinth MC, Mull M. Vetebral artery loop causing cervical
radiculopathy. Surg Neurol. 2007;67:172–3.
89. Barr ML. Blood supply of the central nervous system. In: Barr
ML, editor. The human nervous system. 3rd ed. Philadelphia:
Harper Row; 1979. p. 293–303.
90. Huntoon MA. Anatomy of the cervical intervertebral foramina:
vulnerable arteries and ischemic neurologic injuries after trans-
foraminal epidural injections. Pain. 2005;117:104–11.
Curr Rev Musculoskelet Med (2009) 2:30–42 41
91. Chakravorty BG. Arterial supply of the cervical spinal cord (with
special reference to the radicular arteries). Anat Rec. 1971;170:
311–30.
92. Turnbull IM, Brieg A, Hassler O. Blood supply of cervical spinal
cord in man. A microangiographic study. J Neurosurg. 1966;24:
951–65.
93. Derby R. Point of view: cervical epidural steroid injection with
intrinsic spinal cord damage: two case reports. Spine.
1998;23:2141–2.
94. Lieberman R, Dreyfuss P, Baker R. Fluoroscopically guided
interlaminar cervical epidural injections. Letter to the Editor.
Arch Phys Med Rehabil. 2003;84:1568.
42 Curr Rev Musculoskelet Med (2009) 2:30–42
